laitimes

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

author:Dimai Biologics

From October 26th to 28th, the 19th International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo (2022 CACLP) was held in Nanchang, Hero City. This time, Timai brought new products of high-end blood cell series to the 2022 CACLP and participated in the grand event with industry colleagues.

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Dimaixing Xingyun intelligent inspection

Dimai unlocks imagination, illuminates innovation, and climbs from one peak to another beyond the limit. The new products of Timind's high-end blood cell series break through the boundaries of traditional definition, share AI intelligent analysis, and achieve an innovation-led future pattern. On the 26th, the new product launch of Timind's high-end blood cell series was unveiled under the attention of many experts, scholars and professional audiences.

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

As the debut of Timind's high-end blood cell series products, TiMindi is honored to invite Professor Wang Chuanxin, Chairman-designate of the Laboratory Medicine Branch of the Chinese Medical Association, Professor Fu Weiling, Vice Chairman of the Laboratory Branch of the Chinese Medical Association, Professor Wang Hualiang, Chairman of the Experimental Medicine Branch of the National Health Industry Enterprise Management Association, and Professor Li Rong, Administrative Director of the Department of Clinical Laboratory, Jiangxi Provincial People's Hospital, to attend the press conference.

In his speech, Professor Wang Chuanxin affirmed the determination and achievements of Dimai in the field of in vitro diagnostics for many years, and the newly launched high-end blood cell series products, using nucleic acid fluorescence three-dimensional analysis technology, and AI artificial intelligence innovation integration, will have more powerful screening capabilities for abnormal samples, and look forward to the launch of more high-quality products to help the further development of testing, hoping that domestic medical device brands will shine. Professor Fu Weiling congratulated Dimai and looked forward to more domestic IVD enterprises to build China's IVD brand image. Professor Wang Hualiang said that the domestic IVD industry is developing very rapidly, and the creative joint testing of Dimai is the first initiative of Chinese enterprises. Professor Li Rong fully affirmed the positioning of Timei as an innovator, and more convenient, efficient and accurate testing will better serve clinics and patients.

Subsequently, Mr. Zhai Liuwei, President of TiMei, first thanked the expert teachers and the audience for their attention and support, and will adhere to innovation and leadership, customer-centric, expand product lines, and continuously launch high-quality products and services to help improve the efficiency and accuracy of diagnosis and treatment in medical institutions.

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Under the witness of on-site experts and audiences, the new products of Timind's high-end blood cell series were officially released!

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Fully automatic hematology analyzer DH-615

New nucleic acid fluorescence 3D analysis technology, innovative AI intelligent assisted analysis

Fully automatic peripheral blood intelligent detection, abnormal samples automatically regressed and re-examined

Modular and flexible expansion, providing multi-form product solutions

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Fully automatic blood cell analysis line DH-2000

The maximum detection speed of blood routine can reach 200 samples per hour

Meet the needs of efficient testing with large sample sizes

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Automatic blood immunoassay analyzer DH-2000T

Routine blood is achieved through a tube of blood

+CRP/SAA/PCT/IL-6 multiple joint inspections

More convenient and more clinically valuable

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Dimai innovation never stops, "emperor" creates fluorescence, wisdom "pole" connection. The AI-assisted expert system equipped with Timind's high-end blood cell series products will continue to be iteratively upgraded to improve the efficiency of clinical blood routine abnormal sample screening and diagnosis and treatment level.

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

In addition to new products, DM79X, CA520, DP-H10 and other DyMed fist products are also available.

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled
Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled

Dimi adheres to innovation leadership, customer-centric, and solves customer pain points. All Dimai people will, as always, bravely climb the peak of inspection and care for life and health with innovative medical treatment.

Dimai @ CACLP | The collision between inspection and AI, the new products of Timind's high-end blood cell series were amazingly unveiled